Equillium, Inc. (EQ): Total Assets
$31.89M
As of 2025-12-31
$58.67M
As of 2026-06-30
-25.9%
3-year compound annual growth
-17.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $31.89M | +24.5% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $25.60M | -49.3% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $50.53M | -35.6% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $78.42M | -8.2% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $85.41M | 0.0% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $85.43M | +53.8% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $55.54M | -17.3% | 2021-03-24, Balance as of period end |
| 2018-12-31 | $67.16M | +839.2% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $7.15M | n/a | 2019-03-27, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Equillium, Inc. (EQ) | 2025-12-31 | $31.89M | +24.5% |
| Nuvectis Pharma, Inc. (NVCT) | 2025-12-31 | $31.71M | +70.4% |
| Tvardi Therapeutics, Inc. (TVRD) | 2025-12-31 | $32.07M | -8.9% |
| Valion Bio, Inc. (VBIO) | 2025-12-31 | $31.61M | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $31.00M | +108.2% |
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | $30.49M | -32.8% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $30.16M | -54.9% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $30.08M | -1.6% |
Compare EQ, NVCT, TVRD, VBIO side by side · Screen every company in Pharmaceutical Preparations ↗